Tables

Table TDI-1. Sources for data on clients entering treatment in 2003

Table TDI-2 part (i). Numbers of clients entering treatment and numbers of reporting treatment centres, 1996 to 2003. Total numbers of new clients entering treatment

Table TDI-2 part (ii). Numbers of clients entering treatment and numbers of reporting treatment centres, 1996 to 2003. Total numbers of all clients entering treatment

Table TDI-2 part (iii). Numbers of clients entering treatment and numbers of reporting treatment centres, 1996 to 2003. Numbers of treatment units covered for reporting clients entering treatment

Table TDI-2 part (iv). Numbers of clients entering treatment and numbers of reporting treatment centres, 1996 to 2003. Types of units covered for reporting clients entering treatment

Table TDI-3 part (i). Distribution by primary drug used of new clients entering treatment, 1993 to 2003. Percentage of new clients using heroin

Table TDI-3 part (ii). Distribution by primary drug used of new clients entering treatment, 1993 to 2003. Percentage of new clients using cocaine

Table TDI-3 part (iii). Distribution by primary drug used of new clients entering treatment, 1993 to 2003. Percentage of new clients using cannabis

Table TDI-3 part (iv). Distribution by primary drug used of new clients entering treatment, 1993 to 2003. Percentage of new clients using stimulants

Table TDI-4 part (i). Characteristics of new clients entering treatment: demographics and primary drug at treatment in 2003 or most recent year available. Demographics and injecting status

Table TDI-4 part (ii). Characteristics of new clients entering treatment: demographics and primary drug at treatment in 2003 or most recent year available. Primary drug type used (percentage of new clients using) and of those, the percentage injecting it

Table TDI-5 part (i). Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2003 or most recent year available. Demographics and injecting status of all clients entering treatment

Table TDI-5 part (ii). Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2003 or most recent year available. Primary drug type used by clients (percentage of all clients) and of those, the percentage injecting it

Table TDI-5 part (iii). Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2003 or most recent year available. Demographics and injecting status of all men entering treatment

Table TDI-5 part (iv). Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2003 or most recent year available. Demographics and injecting status of all women entering treatment

Table TDI-5 part (v). Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2003 or most recent year available. Primary drug type used by male clients (percentage of all male clients)

Table TDI-5 part (vi). Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2003 or most recent year available. Primary drug type used by female clients (percentage of all female clients)

Table TDI-6. Trends in gender distribution among new clients entering treatment from 1992 to 2003 (expressed as males/females ratio)

Table TDI-7. Incidence of treatment demands for drug use: new clients entering treatment in 2003 (rate per 100000 population)

Table TDI-8. Number of cases covered by the treatment demand indicator schedule reports: new clients and all clients entering treatment in 2003, by type of treatment centre

Table TDI-9. Clients entering outpatient treatment: mean age and gender distribution among new and all clients in 2003

Table TDI-10 part (i). New clients entering outpatient treatment: age and primary drug at treatment in 2003 for those countries supplying data. Age distribution (row percentage) for each primary drug type: summary

Table TDI-10 part (ii). New clients entering outpatient treatment: age and primary drug at treatment in 2003 for those countries supplying data. Distribution of primary drug used (column percentage) in each age group: summary

Table TDI-10 part (iii). New clients entering outpatient treatment: age and primary drug at treatment in 2003 for those countries supplying data. Number of clients using opiates as primary drug

Table TDI-10 part (iv). New clients entering outpatient treatment: age and primary drug at treatment in 2003 for those countries supplying data. Number of clients using cocaine as primary drug

Table TDI-10 part (v). New clients entering outpatient treatment: age and primary drug at treatment in 2003 for those countries supplying data. Number of clients using stimulants as primary drug

Table TDI-10 part (vi). New clients entering outpatient treatment: age and primary drug at treatment in 2003 for those countries supplying data. Number of clients using hallucinogens as primary drug

Table TDI-10 part (vii). New clients entering outpatient treatment: age and primary drug at treatment in 2003 for those countries supplying data. Number of clients using hypnotics as primary drug

Table TDI-10 part (viii). New clients entering outpatient treatment: age and primary drug at treatment in 2003 for those countries supplying data. Number of clients using volatile inhalants as primary drug

Table TDI-10 part (ix). New clients entering outpatient treatment: age and primary drug at treatment in 2003 for those countries supplying data. Number of clients using cannabis as primary drug

Table TDI-10 part (x). New clients entering outpatient treatment: age and primary drug at treatment in 2003 for those countries supplying data. Number of clients using other drugs as primary drugs

Table TDI-11 part (i). New clients entering outpatient treatment: age at first use of primary drug at treatment in 2003 for those countries supplying data. Distribution of age at first use (row percentage) for each primary drug type: summary

Table TDI-11 part (ii). New clients entering outpatient treatment: age at first use of primary drug at treatment in 2003 for those countries supplying data. Distribution of primary drug used (column percentages) in each age group: summary

Table TDI-11 part (iii). New clients entering outpatient treatment: age at first use of primary drug at treatment in 2003 for those countries supplying data. Number of clients using opiates as primary drug

Table TDI-11 part (iv). New clients entering outpatient treatment: age at first use of primary drug at treatment in 2003 for those countries supplying data. Number of clients using cocaine as primary drug

Table TDI-11 part (v). New clients entering outpatient treatment: age at first use of primary drug at treatment in 2003 for those countries supplying data. Number of clients using stimulants as primary drug

Table TDI-11 part (vi). New clients entering outpatient treatment: age at first use of primary drug at treatment in 2003 for those countries supplying data. Number of clients using hypnotics and sedatives as primary drug

Table TDI-11 part (vii). New clients entering outpatient treatment: age at first use of primary drug at treatment in 2003 for those countries supplying data. Number of clients using hallucinogens as primary drug

Table TDI-11 part (viii). New clients entering outpatient treatment: age at first use of primary drug at treatment in 2003 for those countries supplying data. Number of clients using volatile inhalants as primary drug

Table TDI-11 part (ix). New clients entering outpatient treatment: age at first use of primary drug at treatment in 2003 for those countries supplying data. Number of clients using cannabis as primary drug

Table TDI-11 part (x). New clients entering outpatient treatment: age at first use of primary drug at treatment in 2003 for those countries supplying data. Number of clients using other drugs as primary drugs

Table TDI-12. New clients entering outpatient treatment: distribution of educational level (percentage) in 2003 for countries reporting data

Table TDI-13. New clients entering outpatient treatment: distribution (percentage) of labour status in 2003 for countries supplying data

Table TDI-14. All clients entering outpatient treatment: distribution (percentage) by accommodation arrangements (persons with whom the client is living) in 2003 for countries submitting data

Table TDI-15. All clients entering outpatient treatment: living conditions in 2003 for countries supplying data

Table TDI-16. New clients entering outpatient treatment: distribution (percentage) by source of referral in 2003 for countries supplying data

Table TDI-17 part (i). Route of administration of primary drug among new outpatient clients in 2003. Percentage among clients with opiates as primary drug

Table TDI-17 part (ii). Route of administration of primary drug among new outpatient clients in 2003. Percentage among clients with cocaine as primary drug

Table TDI-17 part (iii). Route of administration of primary drug among new outpatient clients in 2003. Percentage among clients with stimulants as primary drug

Table TDI-17 part (iv). Route of administration of primary drug among new outpatient clients in 2003. Percentage among clients with hypnotics and sedatives as primary drug

Table TDI-18 part (i). Frequency of use of primary drug among new outpatient clients in 2003. Percentage among clients with opiates as primary drug

Table TDI-18 part (ii). Frequency of use of primary drug among new outpatient clients in 2003. Percentage among clients with cocaine as primary drug

Table TDI-18 part (iii). Frequency of use of primary drug among new outpatient clients in 2003. Percentage among clients with stimulants as primary drug

Table TDI-18 part (iv). Frequency of use of primary drug among new outpatient clients in 2003. Percentage among clients with cannabis as primary drug

Table TDI-18 part (v). Frequency of use of primary drug among new outpatient clients in 2003. Percentage among clients with hypnotics and sedatives as primary drug

Table TDI-19. New clients entering outpatient treatment: distribution by primary drug at treatment in 2003 for those countries supplying data

Table TDI-20. All clients entering outpatient treatment: distribution by primary drug at treatment in 2003 for those countries supplying data

Table TDI-21. Unemployment rates among new clients entering outpatient treatment in 2003 and in the general population aged 15 to 74 for countries providing data

Table TDI-22. Gender ratio (ratio of males to females) among new clients entering outpatient treatment by primary drug - opiates, cannabis, cocaine, other stimulants - in 2003 for countries providing data

Table TDI-23. New clients entering outpatient treatment for primary use of amphetamines and ecstasy in 2003 for countries supplying data

Table TDI-24. New clients entering outpatient treatment - distribution of secondary drug used at treatment in 2003 for countries supplying data

Table TDI-25 part (i). Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2003: the combination of cannabis, opiates, cocaine or other stimulants as primary drug type with a secondary drug. All clients with cannabis as primary drug: numbers reporting the stated drug as secondary

Table TDI-25 part (ii). Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2003: the combination of cannabis, opiates, cocaine or other stimulants as primary drug type with a secondary drug. All clients with opiates as primary drug: numbers reporting the stated drug as secondary

Table TDI-25 part (iii). Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2003: the combination of cannabis, opiates, cocaine or other stimulants as primary drug type with a secondary drug. All clients with cocaine as primary drug: numbers reporting the stated drug as secondary

Table TDI-25 part (iv). Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2003: the combination of cannabis, opiates, cocaine or other stimulants as primary drug type with a secondary drug. All clients with stimulants other than cocaine as primary drug: numbers reporting the stated drug as secondary

Table TDI-26. Polydrug use among all clients entering outpatient treatment - summary over all countries supplying data for 2003 of most frequently used secondary drugs, as percentages of primary users of cannabis, opiates, cocaine or other stimulants